(Q57972006)

3

object named as

Madhav Thambisetty

0 references

Cristina Legido-Quigley

5

object named as

Cristina Legido-Quigley

0 references

author name string

Nicola Greenberg

1

0 references

Antonio Grassano

Biomarkers of Alzheimer disease in plasma

2

0 references

publication date

April 2009

0 references

published in

Electrophoresis

0 references

volume

30

0 references

page(s)

1235-1239

0 references

issue

7

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Biomarkers for Alzheimer’s disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Discovery and development of biomarkers of neurological disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Proteome-based plasma biomarkers for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Chemometrics in metabonomics.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Diagnosing Alzheimer's disease--non-clinicians and computerised algorithms together are as accurate as the best clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Evaluation of factors of importance for clinical dementia diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Evaluation of a protocol for metabolic profiling studies on human blood plasma by combined ultra-performance liquid chromatography/mass spectrometry: From extraction to data analysis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Choline metabolism as a basis for the selective vulnerability of cholinergic neurons

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Evidence for a membrane defect in Alzheimer disease brain

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brain.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Targeting bile-acid signalling for metabolic diseases

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Mild cognitive impairment: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

Oxysterols, cholesterol homeostasis, and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800589

7 January 2021

https://api.crossref.org/works/10.1002%2FELPS.200800589

1 reference

7 January 2021